0000899243-17-019539.txt : 20170802 0000899243-17-019539.hdr.sgml : 20170802 20170802163019 ACCESSION NUMBER: 0000899243-17-019539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170801 FILED AS OF DATE: 20170802 DATE AS OF CHANGE: 20170802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho Tony W CENTRAL INDEX KEY: 0001713637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 171000330 MAIL ADDRESS: STREET 1: CRISPR THERAPEUTICS AG STREET 2: 610 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-01 0 0001674416 CRISPR Therapeutics AG CRSP 0001713637 Ho Tony W C/O CRISPR THERAPEUTICS, INC. 610 MAIN ST. CAMBRIDGE MA 02139 0 1 0 0 See Remarks Restricted Stock Units 2017-08-01 4 A 0 75000 0.00 A Common Shares 75000 75000 D Stock Options (Right to Buy) 16.90 2017-08-01 4 A 0 260000 0.00 A 2027-08-01 Common Shares 260000 260000 D Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. The restricted stock units vest in two equal annual installments on 8/1/2018 and 8/1/2019. This option was granted on August 1, 2017 with respect to 260,000 Common Shares of which 25% shall vest on 8/1/2018 and the remaining 75% shall vest in 36 equal monthly installments on the final day of each succeeding calendar month. Executive Vice President, Head of Research & Development /s/ James R. Kasinger, attorney-in-fact 2017-08-02